These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3065095)

  • 61. [Effect of aging on blood catecholamine under 3 conditions of sodium intake--comparison between normal subjects and patients with essential hypertension].
    Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
    Nihon Naibunpi Gakkai Zasshi; 1983 Sep; 59(9):1276-85. PubMed ID: 6642012
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of clonidine on renin and aldosterone of hypertensive patients.
    Salvetti A; Pedrinelli R; Cavasinni L; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):50-6. PubMed ID: 6989768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of sodium supplementation during energy restriction on plasma norepinephrine levels in obese women.
    Gougeon R; Mitchell TH; Larivière F; Abraham G; Montambault M; Marliss EB
    J Clin Endocrinol Metab; 1991 Nov; 73(5):975-81. PubMed ID: 1939535
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship between plasma renin activity and urinary catecholamines in various types of hypertension.
    Horký K; Kopecká J; Greogorová I; Dvoráková J
    Endokrinologie; 1976 Jul; 67(3):331-42. PubMed ID: 976208
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Blood pressure and hormone changes associated with weight reduction in the obese.
    Sowers JR; Nyby M; Stern N; Beck F; Baron S; Catania R; Vlachis N
    Hypertension; 1982; 4(5):686-91. PubMed ID: 7049921
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man.
    Whitfield L; Sowers JR; Tuck ML; Golub MS
    J Clin Endocrinol Metab; 1980 Oct; 51(4):724-9. PubMed ID: 6252224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathophysiological role of dopamine on the development of hypertension in rats.
    Yoshimura M; Kambara S; Okabayashi H; Ikegaiki I; Matsuzawa M; Suga K; Takahashi H; Ijichi H
    Jpn Circ J; 1987 Oct; 51(10):1226-31. PubMed ID: 3430692
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Circadian changes in plasma renin activity and plasma aldosterone concentration in two-kidney hypertension rats.
    DeForrest JM; Davis JO; Freeman RH; Stephens GA; Watkins BE
    Hypertension; 1979; 1(2):142-9. PubMed ID: 399940
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma sodium-potassium ATPase inhibition activity in low- and normal-renin hypertension.
    Keane P; Burgess E; Watanabe M; Wong T
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):9-13. PubMed ID: 1848765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endogenous dopaminergic activity in Child-Pugh A cirrhosis: potential role in renal sodium handling and in the maintenance of clinical compensation.
    Sansoè G; Ferrari A; Baraldi E; Grisolia C; De Santis MC; Villa E; Manenti F
    Eur J Clin Invest; 1998 Feb; 28(2):131-7. PubMed ID: 9541127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High and low sodium acetate haemodialysis and ultrafiltration. II. Comparison of plasma renin activity (PRA), catecholamine levels (CA) and plasma aldosterone concentration (PAC).
    Solski J; Kiazek A; Spasiewicz D
    Int Urol Nephrol; 1986; 18(3):341-7. PubMed ID: 3533826
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dopamine and nonmodulating hypertension.
    Williams GH; Gordon MS; Stuenkel CA; Conlin PR; Hollenberg NK
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):112S-115S. PubMed ID: 2383375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prolactin secretion in essential hypertension.
    Stern N; Eshkol A; Lunenfeld B; Rosenthal T
    Clin Exp Hypertens A; 1983; 5(4):543-58. PubMed ID: 6342865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endocrine, renal, and hemodynamic responses to graded dopamine infusions in normal men.
    Levinson PD; Goldstein DS; Munson PJ; Gill JR; Keiser HR
    J Clin Endocrinol Metab; 1985 May; 60(5):821-6. PubMed ID: 3920231
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
    Stern N; Sowers JR; Tuck M; Eshkol A; Lunenfeld B; Rosenthal T
    J Hypertens; 1984 Apr; 2(2):209-14. PubMed ID: 6398336
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Studies on the blood pressure control mechanism in essential hypertension: the relation of plasma norepinephrine concentrations to plasma renin activity and haemodynamics (author's transl)].
    Shigetomi S; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1980 Jan; 56(1):78-86. PubMed ID: 6987097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.